Kieran Murphy is President and CEO of GE Healthcare as of June 2017. In this role, he is responsible for helping provide transformational medical technologies and solutions to the global healthcare industry. GE Healthcare supports customers in over 100 countries with a broad range of services and systems, from diagnostic imaging, monitoring and digital solutions through to molecular diagnostics and life-sciences.
Kieran joined GE Healthcare in 2008 from Whatman plc. In 2011, Kieran was named President and Chief Executive Officer of GE Healthcare Life Sciences, a molecular medicine business that provides a broad range of industry-leading technologies and services for drug discovery, pre-clinical and clinical development and biopharmaceutical manufacturing, as well as molecular tools for diagnostics, therapy selection and treatment monitoring in patient care. In this role, he oversaw significant revenue growth and geographic expansion of the molecular medicine business.
Prior to joining GE, Kieran worked with Janssen Pharmaceutical, a division of Johnson and Johnson, followed by leadership roles with Mallinckrodt, veterinary medicines provider Vericore, Novartis, Adprotech, ML Laboratories and Innovata plc.